FDA, CMS To Begin Collaborating On Drug Safety Data Collection In 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS Medical Innovation Task Force report says CMS will assist FDA in postmarketing drug surveillance. The collaboration also includes parallel reviews by the two agencies to minimize delays between marketing approval and reimbursement.